Jim Simons’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCY
IAIM
CCM
Jim Simons's ONCY Position: Q2 2026 in Review
Jim Simons reduced its Oncolytics Biotech (ONCY) stake by 91% in Q2 2026, selling an estimated $606K and leaving 62,010 shares worth $58.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3037.
Jim Simons first reported a position in ONCY in Q3 2018 and has held it in 15 quarters since. The position peaked at $608K in Q1 2026. 76 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.
- Jim Simons held 62,010 shares of Oncolytics Biotech worth $58.9K as of Q2 2026.
- Jim Simons sold 653,828 Oncolytics Biotech shares in Q2 2026, an estimated $606K.
- Oncolytics Biotech made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #3037 holding.
- Jim Simons first reported a position in Oncolytics Biotech in Q3 2018 and has held it in 15 quarters since.
- Jim Simons's Oncolytics Biotech position peaked at $608K in Q1 2026.
- 76 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.